Ryvu Therapeutics completes construction of R&D center

By The Science Advisory Board staff writers

June 2, 2020 -- Clinical-stage biopharmaceutical company Ryvu Therapeutics has completed the construction of its Research and Development (R&D) Center for Innovative Drugs.

The center will help Ryvu expand and accelerate its drug research, the company noted. It features 32,300 square feet of laboratory space and will house multiple types of laboratories, including medicinal chemistry, biochemistry, cell and molecular, and analytical chemistry.

The six-floor facility is located in a special economic zone of Krakow, Poland, that provides tax incentives for local companies. It is also near Jagiellonian University and on a street named in honor of the doctor who created the commonly prescribed drug Valium.

Ryvu has obtained occupancy permits and intends to move into the new headquarters at the end of June 2020. However, an official public opening ceremony will not take place until the fall to comply with COVID-19 pandemic regulations.

New COVID-19 R&D initiatives announced
A series of new initiatives aims to simplify scientific literature discovery and acquisition during the COVID-19 crisis, according to Research Solutions....
Universal flu vaccine R&D collaboration established
Clinical-stage biopharmaceutical company TFF Pharmaceuticals has partnered with researchers at the University of Georgia and University of Texas to evaluate...
Funding floodgates open for COVID-19 research
The impacts of the COVID-19 pandemic are being felt around the world. Researchers are working at a record-setting pace to understand the novel coronavirus...
zPredicta partners with LabCorp for cell cultures R&D
LabCorp and zPredicta have partnered to promote the use of 3D cell cultures for drug research and development.
Merck to build new biotech R&D center in Switzerland
Merck announced on January 27 an investment of 250 million euros ($275 million) to build a new biotech R&D center in Corsier-sur-Vevey, Switzerland.

Copyright © 2020 scienceboard.net

Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
BioProcess International Europe
July 13-17
Central European Time Zone (CET) Netherlands
2020 ACCP Annual Meeting
September 20-22
Bethesda, Maryland United States
Bioprocess International West
September 21-24
Eastern Standard Time Zone (EST) United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter